Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,751 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants: Impact of household exposure in hospital healthcare workers.
Tani N, Ikematsu H, Goto T, Kondo S, Gondo K, Fujiyoshi N, Minami J, Harada Y, Nagano S, Horiuchi T, Kuwano H, Akashi K, Shimono N, Chong Y. Tani N, et al. Among authors: horiuchi t. Vaccine. 2023 Oct 26;41(45):6672-6678. doi: 10.1016/j.vaccine.2023.09.051. Epub 2023 Sep 27. Vaccine. 2023. PMID: 37775465 Free article.
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
Kashiwado Y, Kimoto Y, Ohshima S, Sawabe T, Irino K, Nakano S, Hiura J, Yonekawa A, Wang Q, Doi G, Ayano M, Mitoma H, Ono N, Arinobu Y, Niiro H, Hotta T, Kang D, Shimono N, Akashi K, Takeuchi T, Horiuchi T. Kashiwado Y, et al. Among authors: horiuchi t. Rheumatology (Oxford). 2024 Mar 1;63(3):725-733. doi: 10.1093/rheumatology/kead275. Rheumatology (Oxford). 2024. PMID: 37289506
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.
Kashiwado Y, Kimoto Y, Sawabe T, Irino K, Nakano S, Hiura J, Wang Q, Kawano S, Ayano M, Mitoma H, Ono N, Arinobu Y, Niiro H, Hotta T, Kang D, Akashi K, Ohshima S, Takeuchi T, Horiuchi T. Kashiwado Y, et al. Among authors: horiuchi t. Mod Rheumatol. 2023 Mar 2;33(2):367-372. doi: 10.1093/mr/roac030. Mod Rheumatol. 2023. PMID: 35411376 Free PMC article.
Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study.
Ayano M, Kimoto Y, Mitoma H, Akahoshi M, Ono N, Arinobu Y, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: horiuchi t. Ther Adv Musculoskelet Dis. 2022 May 13;14:1759720X221096367. doi: 10.1177/1759720X221096367. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35586513 Free PMC article.
1,751 results